Do you have the same question? Follow this Question
Jan 22, 2026 - 01:03 PM
We’ve provided several answers to questions related to Bimzelx (Bimekizumab) , see some other helpful Q&A related to this product.
Question: Is this medication self-administered?
Answer: Yes, it is designed for self-injection, so patients can give themselves the medication at home. Self-administration offers convenience and can reduce the need for frequent doctor visits.
Question: What is the DrugBank identifier for this medication?
Answer: The DrugBank ID is DB15110. DrugBank is an online database containing detailed drug information, which can be helpful for healthcare professionals and patients seeking more in-depth scientific data.
Question: What is the route of administration for this medication?
Answer: It is given as a subcutaneous injection, meaning it is injected under the skin. This route allows patients to self-administer the medication at home, making ongoing treatment more convenient.
